A laser-induced graphene-based electrochemical immunosensor for nucleic acid methylation detection

The detection of methylation in DNA and RNA is essential for the diagnosis and treatment of a wide range of diseases. A one-step fabricated laser-induced graphene (LIG) electrode has received increasing attention due to its good electrical conductivity, large specific surface area, ease of miniaturization, low cost and flexibility. Herein, a potential biosensor for N6-methyladenosine (m6A-RNA) and 5-methylcystosine-single strand DNA (5mC-ssDNA) detection was designed. The aim of this paper is to address the problem of detecting the m6A-RNA and 5mC-ssDNA content in cells. By stepwise modification of gold nanoparticles (AuNPs), sulfhydryl-modified nucleic acid chains, biotin-modified antibodies, and streptavidin-modified horseradish peroxidase (SA-HRP) at the LIG electrode, the peak current responses exhibited an increase proportional to the concentration of m6A-RNA and 5mC-ssDNA in the hydrogen peroxide-hydroquinone (H2O2-HQ) system. This method demonstrated a low detection limit of 2.81 pM for m6A-RNA and 9.53 pM for 5mC-ssDNA, with a linear detection range of 0.01 nM to 10 nM for both targets. The regression equation was determined as ΔI = 4.83 log c + 12.32 (R2 = 0.9980) for m6A-RNA and ΔI = 9.82 log c + 22.09 (R2 = 0.9903) for 5mC-ssDNA. Our method has good selectivity toward different detection targets of nucleic acid chains, stability for long-term storage and consecutive scanning (RSD of 9.42% and 2.08%, respectively) and reproducibility of 5 electrodes (RSD of 6.85%). This method utilizes gold-sulfur bonding to immobilize the detection target, which improves the conductivity of the LIG electrode and introduces an amplified portion of the signal by taking advantage of antigen-antibody specific binding. Thus, dual detection of m6A-RNA and 5mC-ssDNA was realized. Importantly, this approach is successfully applied for the detection of targets in spiked samples extracted from HeLa cells, suggesting its potential for clinical applications and providing a new perspective for the development of point-of care testing (POCT) techniques.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:149

Enthalten in:

The Analyst - 149(2023), 1 vom: 18. Dez., Seite 137-147

Sprache:

Englisch

Beteiligte Personen:

Guo, Jingyi [VerfasserIn]
Zhao, Mei [VerfasserIn]
Chen, Chen [VerfasserIn]
Wang, Fang [VerfasserIn]
Chen, Zilin [VerfasserIn]

Links:

Volltext

Themen:

63231-63-0
7440-57-5
7782-42-5
9007-49-2
BBX060AN9V
DNA
Gold
Graphite
Hydrogen Peroxide
Journal Article
RNA

Anmerkungen:

Date Completed 19.12.2023

Date Revised 19.12.2023

published: Electronic

Citation Status MEDLINE

doi:

10.1039/d3an01628e

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM364780266